Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. (Q40549500)
Jump to navigation
Jump to search
scientific article published on October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. |
scientific article published on October 2003 |
Statements
1 reference
Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. (English)
1 reference
Shigetaka Asano
1 reference
Katsuaki Sato
1 reference
Mariko Morishita
1 reference
Kaoru Uchimaru
1 reference
Naoki Oyaizu
1 reference
Takeshi Inazawa
1 reference
Tomoko Yamasaki
1 reference
Makoto Enomoto
1 reference
Takashi Nakaoka
1 reference
Tetsuya Nakamura
1 reference
Taira Maekawa
1 reference
Akifumi Yamamoto
1 reference
Shinji Shimada
1 reference
Toshiaki Saida
1 reference
Yutaka Kawakami
1 reference
Kenzaburo Tani
1 reference
Tsuneo A Takahashi
1 reference
Naohide Yamashita
1 reference
1 October 2003
1 reference
1 reference
Identifiers
1 reference